Understanding the Regulatory Perspective in Bioequivalence Studies
Introduction The pharmaceutical industry is continuously evolving, driven by the need for innovative therapies and affordable medications. Central to this evolution is the concept of bioequivalence, particularly in the context of generic drug development. Bioequivalence studies are crucial for demonstrating that
